CWC
ANIK icon

Carolinas Wealth Consulting’s Anika Therapeutics ANIK Stock Holding History

Carolinas Wealth Consulting’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-142
Closed -$4K – 883
2022
Q1 		$4K Hold
142
– – ﹤0.01% 711
2021
Q4 		$5K Hold
142
– – ﹤0.01% 697
2021
Q3 		$6K Hold
142
– – ﹤0.01% 643
2021
Q2 		$6K Hold
142
– – ﹤0.01% 666
2021
Q1 		$6K Hold
142
– – ﹤0.01% 672
2020
Q4 		$6K Hold
142
– – ﹤0.01% 625
2020
Q3 		$5K Buy
+142
New +$5.13K ﹤0.01% 557

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Carolinas Wealth Consulting's ANIK Position: Q2 2022 in Review

Carolinas Wealth Consulting sold out of Anika Therapeutics (ANIK) in Q2 2022, closing a stake of 142 shares — an estimated $4K sold.

Carolinas Wealth Consulting first reported a position in ANIK in Q3 2020 and held it in 7 quarters. The position peaked at $6K in Q3 2021. 125 funds tracked by Wall St. Rank hold ANIK as of Q2 2022.

  • Carolinas Wealth Consulting reported no remaining Anika Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 142 Anika Therapeutics shares in Q2 2022, an estimated $4K.
  • Carolinas Wealth Consulting first reported a position in Anika Therapeutics in Q3 2020 and held it in 7 quarters.
  • Carolinas Wealth Consulting's Anika Therapeutics position peaked at $6K in Q3 2021.
  • 125 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2022.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2022, filed 16 Aug 2022.